Adjuvant Capital

Venture capital adviser registered with the SEC (exempt reporting adviser), based in New York, NY. Advises 2 venture funds. Latest adviser filing Mar 2026.

“Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges.” (from the firm’s website)

Stages

Seed to Series B

Typical check (est.)

$2.23M–$6.65M

Latest fund

None on file

Last verified activity

Not in the last 12 months